Biotherapeutics Corp Abbott serves as Executive at Trubion Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Biotherapeutics Corp Abbott has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 27, 2010 involved transacting 2,243,649 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 27, 2010 | TRBN | $0 | Other | 2,243,649 | $N/A | Discretionary |
Biotherapeutics Corp Abbott currently holds 0 shares of Trubion Pharmaceuticals, Inc (TRBN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biotherapeutics Corp Abbott has been a net neutral trader of TRBN stock. They have purchased $0 and sold $0 worth of shares.
Biotherapeutics Corp Abbott's most recent insider trade was on Sep 27, 2010, when they sold 2,243,649 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted